Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

The SRM Institute of Science and Technology (SRMIST) has released the results for the third phase of the SRM Joint ...